SEC Form 4 research
| Issuer | ADARx Pharmaceuticals, Inc. |
|---|---|
| Tickers | ADRX |
| Reporting owners | 19 |
| Officers and directors | 6 |
| Last public filing | 2026-09-30 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-30 | 2026-09-28 | Chimovits Erez | P | 61,516 | $17 | Not reported |
| 2026-09-30 | 2026-09-28 | GORDON CARL L | P | 300,249 | $17 | Not reported |
| 2026-09-30 | 2026-09-28 | GORDON CARL L | P | 588,235 | $17 | Not reported |
| 2026-09-30 | 2026-09-28 | GORDON CARL L | P | 61,516 | $17 | Not reported |
| 2026-09-30 | 2026-09-28 | ORBIMED ADVISORS LLC, OrbiMed Advisors Israel II Ltd, OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P. | P | 300,249 | $17 | Not reported |
| 2026-09-30 | 2026-09-28 | ORBIMED ADVISORS LLC, OrbiMed Advisors Israel II Ltd, OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P. | P | 588,235 | $17 | Not reported |
| 2026-09-30 | 2026-09-28 | ORBIMED ADVISORS LLC, OrbiMed Advisors Israel II Ltd, OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC, OrbiMed Israel GP II, L.P. | P | 61,516 | $17 | Not reported |
| 2026-09-29 | 2026-09-28 | SR ONE CAPITAL MANAGEMENT, LLC | P | 592,593 | $17 | Not reported |
| 2026-09-29 | 2026-09-28 | SR ONE CAPITAL MANAGEMENT, LLC | P | 414,814 | $17 | Not reported |
| 2026-09-29 | 2026-09-28 | SR ONE CAPITAL MANAGEMENT, LLC | P | 592,593 | $17 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.